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Production of Hybrid 16-Membered Macrolides
by Expressing Combinations of Polyketide Synthase
Genes in Engineered Streptomyces fradiae Hosts
usual features with respect to formation of the 2,3-trans
double bond.
This work focused on engineering the biosynthesis of
16-MMs related to midecamycin A1 (see Figure 1) to
introduce a chemical handle for attachment of side
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3832 Bay Center Place chains on the left side of the molecule that could poten-
tially enhance antibiotic activity against macrolide-resis-Hayward, California 94545
tant strains. Three macrolide binding regions of the 50S
ribosomal subunit are associated with antibacterial ac-
tivity (1) near the residue corresponding to adenosineSummary
2058 of the 23S rRNA (Escherichia coli numbering) in
domain V, (2) in the peptidyl transferase active site ofCombinations of the five polyketide synthase (PKS)
genes for biosynthesis of tylosin in Streptomyces frad- domain V, and (3) in domain II (hairpin 35) of the 23S
rRNA [18–26]. All macrolides interact with the A2058iae (tylG), spiramycin in Streptomyces ambofaciens
(srmG), or chalcomycin in Streptomyces bikiniensis region and methylation of this residue substantially re-
duces binding and confers high-level resistance [22, 23,(chmG) were expressed in engineered hosts derived
from a tylosin-producing strain of S. fradiae. Surpris- 27]. Midecamycin A1 and other 16-MMs that have an
acyl group extending from the disaccharide componentingly efficient synthesis of compounds predicted from
the expressed hybrid PKS was obtained. The post- can reach into the peptidyl transferase site and inhibit its
activity [20, 21], providing some restoration of potencyPKS tailoring enzymes of tylosin biosynthesis acted
efficiently on the hybrid intermediates with the excep- against resistant strains [28]. Ketolides such as telithro-
mycin, derived from erythromycin by attachment of ation of TylH-catalyzed hydroxylation of the methyl
group at C14, which was efficient if C4 bore a methyl side chain, are active against some macrolide-resistant
pathogens such as Streptococcus pneumoniae [29]. Thegroup, but inefficient if a methoxyl was present. More-
over, for some compounds, oxidation of the C6 ethyl side chain interacts with nucleotides in the domain II
region [26, 29]. Most 16-MMs are not amenable to chem-side chain to an unprecedented carboxylic acid was
observed. By also expressing chmH, a homolog of tylH ical attachment of side groups for domain II binding,
and the PKS engineering described here was aimedfrom the chalcomycin gene cluster, efficient hydroxyl-
ation of the 14-methyl group was restored. at installing such a handle. Specifically, we engineered
hybrid 16-MMs with a 14-hydroxymethyl group that
should allow attachment of side chains via cyclic carba-Introduction
mates between the 14-hydroxymethyl group and an un-
hindered 12,13 double bond, similar to chemistry usedThe 16-membered macrolides (16-MM) are an important
class of antibiotic that are used in human and veterinary in the synthesis of telithromycin [29].
To produce 16-MMs derived from hybrid macrolac-medicine. They are structurally related to the better-
known 14-membered macrolides (see Figure 1). Biosyn- tones consisting of chalcolactone and either platenolide
or tylactone, the first two genes of the chm PKS cluster,thesis begins with assembly of a macrolactone ring by
a modular polyketide synthase (PKS) [1]. Six different encoding the loading and three extender modules, were
expressed along with the last three from either the srm16-membered macrolactone ring structures are known,
from which more than 200 antibiotics are derived or tyl PKS, encoding four extender modules, in specially
constructed S. fradiae hosts in which the native tyl PKS-through different post-PKS tailoring reactions [2]. The
PKSs for all known 16-MMs consist of five large poly- encoding genes were either deleted or inactivated. In
these strains, all or most of the tyl biosynthesis genespeptides with a conserved modular organization. The
involved in post-PKS processing were present. Intro-macrolactone product is determined by the specificities
duction of hybrid PKSs into these hosts resulted in effi-of catalytic domains within each module. Figure 2 shows
cient production of novel structures derived from thethe domain organization for the tylosin (tyl), spiramycin
predicted macrolactone. However, some of these mole-(srm), and chalcomycin (chm) PKSs, as well as the mac-
cules were not efficiently hydroxylated on the 14-methylrolactone product of each enzyme, tylactone, plateno-
group by the TylH hydroxylase. To correct this, a homol-lide, and chalcolactone, respectively. Both the biosyn-
ogous hydroxylase gene from the chalcomycin producerthesis of tylosin and the involvement of genes in the
was introduced.tylosin cluster have been studied extensively [3–14].
Less has been reported on spiramycin biosynthesis, al-
Results and Discussionthough the PKS genes were cloned and sequenced
some time ago [15, 16]. We have recently characterized
Expression of a Hybrid Chalcomycin-Spiramycinthe chalcomycin gene cluster [17] and found some un-
PKS Operon in S. fradiae Yields a Series
of Novel Compounds*Correspondence: reeves@kosan.com
A pSET152-derived vector carrying the chmGI-II-1Present address: ConjuGon, Inc., 505 South Rosa Road, Madison,
Wisconsin 53719. srmGIII-V genes as a single operon was introduced into
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Figure 1. Structures of Macrolide Antibiotics
and Intermediates Relevant to the Develop-
ment of New Antibiotics Using PKS Engi-
neering
S. fradiae K159-1/pKOS244-017a, in which the tylosin 714.85 [MH]. The methanol adduct was also observed,
which is generally diagnostic of an aldehyde function.PKS genes had been deleted [30], and in which the
genes fkbGHIJK for the methoxymalonyl-ACP precursor Upon purification, it was identified by NMR spectrome-
try as 4″-despropionyl-14-methylniddamycin (DPMN,from Streptomyces hygroscopicus had been integrated
at the pSAM2 att site [31]. The methoxymalonyl-ACP Figure 3), a compound derived from 14-methylplateno-
lide. After shake flask fermentation of one of the isolatesprecursor is a required substrate for platenolide PKS
module 5 [31]. The hybrid PKS operon was expressed (S. fradiae K232-192), LC-MS analysis of whole broth
revealed three major compounds: m/z 585.68 [MH],from tylGIp, which was previously shown to be a strong
promoter in S. fradiae [30]. To facilitate construction of m/z 714.85 [MH], and m/z 730.85 [MH], in order of
abundance, as well as a low level of a compound ofthe hybrid operon, the C-terminal interaction domain
[32] of the second chalcomycin PKS polypeptide m/z 905.05 [MH]. Surprisingly, only DPMN and the m/z
905.05 [MH] compound were extracted into ethyl ace-(ChmGII) was replaced with that of the spiramycin PKS
(SrmGII) at a unique HindIII site. Transconjugants were tate, so solid-phase extraction of the spent aqueous
phase was used to recover and purify the m/z 585.68patched on R5 agar, and plugs were screened for bioac-
tivity on Micrococcus luteus. After 7 days growth, most [MH] compound. NMR analysis revealed its structure
to be that of the acidic compound, 6-carboxymethyl-6-plugs gave large zones of inhibition. LC-MS analysis of
an ethyl acetate extract of the agar under these zones desethyl-5-O-mycaminosyl-14-methylplatenolide
(CDMP, Figure 3), in which the C6 ethylaldehyde hadshowed a major peak with a molecular mass of m/z
Figure 2. Comparison of the Domain Struc-
ture for the Tylosin, Spiramycin, and Chalco-
mycin PKSs and the Macrolactone Produced
by Each
At the top is shown the organization of seven
modules on five polypeptides, which is uni-
versally conserved among the 16-MMs. Be-
low that the organization of domains within
each module is shown for the three PKSs:
starter module decarboxylation (KSQ); acyl
transferase with specificity for malonyl, meth-
ylmalonyl, ethylmalonyl, or methoxymalonyl
extender units (AT, ATm, ATe, and ATx, respec-
tively); acyl carrier protein (ACP); ketosyn-
thase (KS); ketoreductase (KR); dehydratase
(DH); enoylreductase (ER); and thioesterase
macrolactonization (TE). The structures of the
PKS products are shown at the bottom with
chalcolactone being the structure obtained
by expression of the chalcomycin PKS in
S. fradiae and not necessarily the structure
obtained from the PKS in its native context
in S. bikiniensis [17].
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Figure 3. Proposed Post-PKS Tailoring Path-
ways for the Chalcolactone-Platenolide Hybrid
The portions of the polyketide core derived
from the corresponding PKS are indicated us-
ing the same color coding as in Figure 2.
been oxidized to the corresponding carboxylic acid, a C-terminal interaction domain of ChmGII may not have
been necessary, since these domains are highly con-feature not previously reported for a 16-MM. It was in-
ferred that the m/z 730.85 [MH] compound was 4-O- served among the 16-MM PKSs, it was clearly not detri-
mental.mycarosyl-CDMP, i.e., it also had the carboxylic acid
(labeled A in Figure 3). The low level of hydroxylation
of the C14 methyl group indicates that intermediates Expression of chmH in S. fradiae K232-192
Enhances 14-Methyl Hydroxylationderived from the chalcolactone-platenolide hybrid struc-
ture are poor substrates for the TylH hydroxylase of the The chalcomycin gene cluster encodes a close homolog
of the TylH hydroxylase, designated ChmH [17]. Eachhost. Oxidation of the aldehyde to the carboxylic acid
may be catalyzed by TylI, which is known to generate has a ferredoxin gene immediately downstream that may
be important for activity or specificity. To determinethe aldehyde through two sequential hydroxylations, or
by an unlinked P450 enzyme that happens to recognize whether the ChmH hydroxylase would accept a chalco-
lactone-platenolide derivative as a substrate for hydrox-the intermediate as a substrate.
Estimation of titers from areas under the peaks at 280 ylation of the C14 methyl group, the chmH gene with
its cognate ferredoxin gene was introduced into the hostnm compared with a standard curve of purified DPMN,
indicated the total polyketide titer was only slightly less expressing the chmGI-II-srmGIII-V hybrid PKS genes
using a modified version of theφBT1-based integratingthan that of tylosin produced by the parent strain under
the same fermentation conditions (2 g/l). Previously, vector, pRT802 [33], carrying tsr for thiostrepton resis-
tance and tylGIp for expression of inserted genes. Intro-the only report of a hybrid PKS composed exclusively
of modules from 16-MM PKSs was the spiramycin PKS duction of chmH had a dramatic affect on the profile of
compounds produced by the strain (Figure 4). Althoughin which the loading domain was exchanged with the
loading domain from the tylosin PKS, resulting in pro- there was still a significant amount of CDMP present,
compounds with masses of m/z [MH] 730.85, 907.04,duction of 15-methylspiramycin [16]. Although an engi-
neered PKS often has reduced catalytic efficiency, either and a trace of 905.04 were also observed. Since these
three compounds could be extracted into ethyl acetatebecause of impaired PKS function through structural
distortion or because the unnatural intermediate is a (Figure 4C), they are inferred to be the compounds la-
beled B, C, and D, respectively, in Figure 3. Althoughpoor substrate for a downstream step, production of
polyketides by this hybrid 16-MM PKS was nearly as only the structures of DPMN and CDMP were verified
by NMR spectrometry, the structures of the other com-efficient as tylosin production by the parent strain. The
functional compatibility between different 16-MM PKS pounds can be inferred from the well-characterized
post-PKS tylosin pathway, the ethyl acetate extractabil-polypeptides presumably reflects the significant se-
quence similarity resulting from relatively recent diver- ity of the compounds, the presence or absence of a
methanol adduct (hemiacetal), and the LC-MS data itselfgence from a common ancestor. Although replacing the
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Figure 4. Effect on the Profile of Products
Derived from Fermentation of the Strain Ex-
pressing the Chalcolactone-Platenolide Hy-
brid PKS when the chmH Gene Is Also Ex-
pressed
Shown are the LC-MS traces at 280 nm with
the masses of specific peaks of interest indi-
cated above. The x axis indicates the time in
minutes from sample injection and the y axis
indicates the absorbance at 280 nm. (A) and
(B) show products from the strain not con-
taining the chmH gene, while (C) and (D) show
products from the strain that did contain this
gene. (A) and (C) show the LC-MS traces for
clarified whole fermentation broth, while (B)
and (D) show the traces for products ex-
tracted from whole broth into ethyl acetate
and the dried residue dissolved in methanol.
(relative retention times and masses). Thus, ChmH can duce a low level of the m/z 905 [MH] compound. Per-
haps a threshold level of the m/z 905 [MH] compoundefficiently hydroxylate the 14-methyl group of the inter-
mediates derived from the chm-srm hybrid PKS, even is required to induce the reductase activity.
though TylH does so very poorly. Figure 3 presents the
post-PKS tailoring pathways for the chalcolactone-plat- Complementation of a KS1 S. fradiae Strain with
the First Two Genes of the Chalcomycin PKSenolide hybrid both in the presence or absence of ChmH.
It appears that once hydroxylation of the 14-methyl Gives a Single Novel Compound
Changing the active site cysteine residue to an alaninegroup occurs, the resulting intermediates are resistant
to oxidation of the aldehyde. in the first keto synthase (KS) domain of the erythromy-
cin PKS blocks synthesis of the product, 6-deoxyer-The first two post-PKS reactions of tylactone are at-
tachment of mycaminose to the C5 hydroxyl by TylMII ythronolide B, but allows appropriate diketides, as their
N-acetylcysteamine thioester derivatives, to be fed toand oxidation of the C6 ethyl side chain to an aldehyde
through two sequential hydroxylations by TylI [4, 6]. All the KS1 host, giving the corresponding macrolactones
and showing that modules 2–6 of the PKS are functionalknown 16-membered macrolactones have a sugar at
the C5 hydroxyl, usually mycaminose, although chalco- in the mutant [36]. When a similar mutation was intro-
duced into the KS1 domain of the tyl PKS of a DMTmycin has chalcose instead [34]. When the macrolac-
tone bears a C6 ethyl side chain, it is always oxidized producer of S. fradiae, i.e., bearing a tylD mutation [5],
feeding of the appropriate diketide thioester also re-to an aldehyde. The enzymes for these first two reactions
in the tylosin pathway apparently have considerable stored production of DMT (data not shown), indicating
that modules 2–7 in the tyl PKS were functional. A syn-substrate tolerance, since all the compounds observed
here had at least these two post-PKS modifications. thetic operon containing the chmGI-II genes under the
control of tylGIp were integrated into the chromosomeAlthough there is a preferred pathway for the post-PKS
reactions in tylosin biosynthesis [4], the order of some of this S. fradiae strain at the φC31 att site using a
derivative of pSET-152 [30]. Although the heterologoussteps is flexible and depends on the relative substrate
tolerance of the enzymes. For example, a tylD mutant ChmGII polypeptide (carrying module 3) can probably
interact appropriately with the host TylGIII polypeptideof S. fradiae produces demycinosyltylosin (DMT) [6],
indicating that attachment of the allose sugar does not (carrying modules 4 and 5), the C-terminal interaction
domain of ChmGII was replaced with the TylGII counter-have to precede attachment of the mycarose sugar.
The significant level of the m/z 907 [MH] compound part to ensure an optimum interaction based on the
results with the ChmGI-II-SrmGIII-V hybrid discussedproduced is believed to result from reduction of the
aldehyde of the m/z 905 [MH] compound to the alcohol. above. The resulting strain (S. fradiae KS1/pKOS342-
84) produced antibiotic activity against M. luteus, andThis reaction converting tylosin to tylosin D is known to
occur in S. fradiae, and the enzyme responsible has LC-MS analysis of the fermentation broths revealed a
compound of m/z 714.88 [MH]. Isolation and NMR anal-been characterized [35]. Apparently, the tylosin analog
derived from expression of the chmGI-II-srmGIII-V hy- ysis showed the structure to be 12,16-didesmethyl-
DMT, in agreement with the prediction. The titer of 12,16-brid PKS is a particularly good substrate for this enzyme.
Strain K232-192 not expressing chmH did not produce didesmethyl-DMT was approximately 0.5 g/l, indicating
that the presence of the inactive TylGI and active TylGIIdetectable m/z 907 [MH] compound, though it did pro-
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production of novel products. The strategy is useful
in cases where there are several highly homologous
sets of PKS genes available that encode the produc-
tion of slightly different structures. Thus, use of the
S. fradiae host strains described here for expression
of PKS gene combinations allows production of 16-
MMs derived from novel macrolactones. The post-
PKS tylosin pathway is generally tolerant of structural
variations, although the TylH hydroxylase could not
hydroxylate the 14-methyl group of one of the hybrids.
In cases where a post-PKS enzyme of the tylosin path-
way will not accept the hybrid structure as a substrate,
there may be an alternative enzyme that can be re-
cruited from another 16-MM pathway, as was demon-
strated for the ChmH hydroxylase.
Experimental Procedures
Strains, Growth Media, and Basic DNA Manipulation
All strains were derived from a tylosin-overproducing S. fradiae
strain [30]. Deletion of the tylosin PKS genes from the strain wasFigure 5. Proposed Post-PKS Tailoring Pathways for the Chalcolac-
described previously [30]. DNA was delivered into S. fradiae strainstone-Tylactone Hybrid in the tylD, KS1 Double Mutant Strain
by conjugative transfer of a mobilizable plasmid from E. coli DH5
See text for details. harboring the RK2-derived helper plasmid pUB307 [30]. The conju-
gation protocol was as described [37], except that overnight incuba-
tion prior to the antibiotic overlay was at 37C. Plasmids were propa-
gated in E. coli DH5 and were constructed using well-establishedpolypeptides did not significantly interfere with the inter-
methods [38]. Antibiotic-resistant exconjugants of S. fradiae wereaction between ChmGI and either ChmGII or TylGII,
streaked for single colonies on AS-1 medium containing the appro-which have identical domain organization and should
priate antibiotics. When exconjugants of a nonproducing host were
both interact with TylGIII. expected to produce a tylosin-related analog, they were patched
Figure 5 shows the post-PKS tailoring pathways lead- onto R5 medium and, after 7 days, plugs were screened for their
ability to form zones of inhibition on lawns of Micrococcus luteusing to the chalcolactone-tylactone hybrid. Since 12,16-
ATCC 9341 growing on Difco medium 11.didesmethyl-DMT was produced efficiently, the pres-
ence or absence of methyl groups on C12 and C16 has
Construction of S. fradiae Strainslittle effect on TylH-catalyzed hydroxylation of the 14-
S. fradiae K264-105.2 contains a deletion of the tylD gene and amethyl group (or the other post-PKS reactions). Al-
null mutation in KS1 of tylGI. Deletion of tylD involved sequentialthough the 14-methyl group of the chmGI-II-tylGIII-V
double homologous crossing over after introduction of a plasmid
hybrid PKS product is efficiently hydroxylated by TylH, carrying regions flanking the gene. The ca. 1.8 kb regions were
neither the product of the chmGI-II-srmGIII-V hybrid isolated by PCR using the following oligonucleotides: 5-GGCATGC
PKS nor the product of the complete chalcomycin PKS CCAGAACCAGTACCCGGTCACATG-3, with 5-GCTGCAGCCCAC
TCGTGAATCCCGAAGGGAAG-3, and 5-CCTGCAGCGTAGTGGG[17] are good substrates for 14-methyl hydroxylation by
AGCCGATGAAGCCCA-3, with 5-GGAATTCCTGACACAGACCGGTylH. This suggests that an oxygen atom on C3 or C4
TCACCGTTCGT-3. This introduced the unique restriction siteswith a particular position relative to the 14-methyl group
(EcoRI-PstI and PstI-SphI). The PCR products were ligated between
may inhibit the TylH hydroxylase. Because the ChmH the EcoRI and SphI sites of pOJ260 [39] giving pKOS168-106, in
hydroxylase presumably evolved to function in the pres- which 80% of the tylD gene was removed and the reading frame
ence of this oxygen, it is perhaps not surprising that it maintained. After conjugation of the E. coli donor with the S. fradiae
K155-3C [30] recipient, apramycin-resistant colonies were obtained,can hydroxylate the chalcolactone-platenolide hybrid.
and those with the plasmid integrated at the tylD locus were identi-
fied by Southern blot hybridization. Growth in the absence of selec-Significance
tion gave S. fradiae K168-173, which had become apramycin sensi-
tive and produced DMT. The KS1 mutation was introduced by
An important goal of PKS engineering is to generate changing the active site cysteine to alanine and introducing a NheI
site. This was accomplished using PCR to make two fragments. Theunique molecules that can be used as starting points
first was a 260 bp fragment made using the oligonucleotides 5-for subsequent chemical modification. The 14-hydro-
ATGGATCCGCAGCAGCCCGTGT-3 and 5-GCTAGCCGCCGTATxymethyl derivatives produced in this study are exam-
CCACGGTCACGG-3. The second was a 370 bp fragment madeples of potential starting points. These compounds
using the oligonucleotides 5-GCTAGCTCGTCGTTGGTGGCGTTG
lack the 12-methyl side chain of tylosin and its interme- CATCT-3 and 5-GCGCATTCCCCAACGCCTGACGAAT-3. The first
diates and should allow cyclization chemistry on the fragment was digested with BamHI and NheI and the second frag-
ment with NheI and BsmI. These two pieces were then ligated intoleft side of the molecules equivalent to that employed
BamHI and BsmI digested pKOS264-65, which is pUC19 containingin ketolide synthesis in the 14-membered macrolide
the ca. 6 kb EcoRV/EcoRI fragment from tylGI, to generategroup. It has also been observed previously that the
pKOS325-8. The insert from pKOS325-8 was isolated by digestioncatalytic efficiency of hybrid or mutant PKS enzymes
with XbaI and PvuII and ligated into pKOS241-52 (derived from
can be significantly reduced. This work shows that pSET152 by cutting with SphI/HindIII, blunting with Klenow Polymer-
coexpression of genes encoding the polypeptides of ase, and self ligating). This suicide plasmid, designated pKOS264-
76, was introduced into S. fradiae K168-173 using an E. coli donor.different, but related, PKSs can give highly efficient
Chemistry & Biology
1470
The first and second crossover events were verified by Southern 8 kb NdeI-SpeI fragment of pKOS232-189 were joined in a three-
fragment ligation and recovered by in vitro packaging (Gigapak Goldblot hybridization and the strain, K264-105.2 was shown to produce
no tylosin-related compounds. However, it did produce DMT when III, Stratagene). The resulting plasmid, pKOS232-184A, was intro-
duced into E. coli DH5/pUB307 and then into S. fradiae K159-1/2(S)-methyl-3(R)-hydroxypentanoyl-N-acetylcysteamine was fed to
the strain (M.M., W.P.R., and L.K., unpublished data). pKOS244-017A by conjugation.
Construction of the host with the tylosin PKS genes deleted
(S. fradiae K159-1) is described elsewhere [30]. Construction of Analysis of Fermentation Products
strain K159-1/pKOS244-017a by introducing a set of genes from the Cultures were grown for 7–8 days at 28C in R media [30]. Culture
FK520 (ascomycin) gene cluster of S. hygroscopicus ATCC 14891 broth samples were prepared for LC-MS analysis by centrifugation
(fkbGHIJK) that provide the precursor methoxymalonyl-ACP is also and filtration through 0.2 m filters or by ethyl acetate extraction,
described elswhere [31]. drying, and dissolution of the residue in methanol. Aqueous samples
were subjected to on-line solid-phase extraction before switching
to the column for fractionation. A Metachem Metasil Basic columnConstruction of Vectors for Expression of PKS Genes
pKOS232-189 is an expression vector similar to pSET152 [39], but (4.6 150 mm, 5 m particle) was used with an 8 min linear gradient
from 35% to 100% buffer B (4:1 MeCN:MeOH, 5 mM NH4Ac) in buffercontaining tylGIp with a NdeI site at the start of transcription, and
a  cos site for packaging of large constructs. The tylGIp was ampli- A (5 mM NH4Ac in water) at a flow rate of 1 ml/min. There was
simultaneous detection by API mass spectrometry (Turbo Ionsprayfied by PCR [30], ligated into the EcoRV site of Litmus38, then
isolated as a NdeI/PstI fragment. This fragment, a 3 kb NdeI/SpeI source) and UV absorption at 280 nm.
fragment of heterologous PKS sequence, and pKOS159-31 [30] cut
with NsiI and SpeI were ligated together to create pKOS232-189. Isolation and Structural Characterization of Compounds
The integrative expression vector, pRT802, was made using the To isolate 4″-despropionyl-14-methylniddamycin (DPMN), clarified
attP site and int genes from the phageφBT1 [33]. Multicloning sites fermentation broth (250 ml) was adjusted to pH 9.5 with 1 N NaOH
were added using a linker made from the following oligonucleotides: and extracted with CHCl3 (3  300 ml). The organic extracts were
5-GGCCGCGTCAATTGGCCGTTAATTAACGCATATGGCCTAGGC combined, dried over Na2SO4, filtered, and concentrated in vacuo
GAGGCCTGCATGCATCCAAGCTTCG-3 and 5-GATCCGAAGCTT to provide an amber oil (1 g). The oil was applied to a silica flash
GGATGCATGCAGGCCTCGCCTAGGCCATATGCGTTAATTAACGG column and eluted with a gradient of 25%–55% acetone/hexane
CCAATTGACGC-3, to give pKOS231-149. The tylGIp was then in- ( 2% NEt3). Fractions eluting in 40% acetone/hexane (2% NEt3)
troduced by digesting the tylGIp/Litmus38 plasmid mentioned were pooled and concentrated in vacuo to provide a solid that was
above with NotI and NdeI and ligating it into pKOS231-149 digested dissolved in a minimum amount of CH2Cl2 and precipitated with
with the same enzymes to create pKOS231-153D. To isolate the hexane. The solvent was removed in vacuo to provide DPMN (0.20 g,
ampicillin resistance gene, Litmus28 was digested with HpaI and 0.283 mmol) as a white powder. 1H NMR (CDCl3, 400 MHz)  ppm
SwaI. This was ligated into pKOS231-153D digested with BspHI 1.06 (d, 3H, J 	 6.4 Hz), 1.19 (m, 9H), 1.24 (m, 6H), 1.48 (m, 1H),
and end-filled with Klenow polymerase to give pKOS231-183D. To 1.56 (m, 1H), 1.72 (d, 1H, J 	 3.4 Hz), 1.85 (m, 1H), 1.99 (d, 1H, J 	
isolate the thiostrepton resistance gene, pIJ5719 (C. Khosla, per- 14.4 Hz), 2.22 (m, 2H), 2.40 (m, 2H), 2.44 (s, 6H), 2.50 (m, 1H), 2.70
sonal communication) was digested with NdeI, end-filled with (m, 2H), 2.90 (m, 1H), 3.09 (d, 1H, J 	 10.0 Hz), 3.23 (m, 2H), 3.48
Klenow Polymerase, and digested with SmaI. This fragment was (dd, 1H, J 	 7.6, 10.4 Hz), 3.51 (s, 3H), 3.75 (d, 1H, J 	 10.0 Hz),
ligated to EcoRV-digested Litmus38 to give pKOS342-106B. This 4.02 (m, 2H), 4.37 (s, 1H, J 	 7.6, 10.4 Hz), 4.82 (dquart, 1H, J 	
was digested with BamHI and HindIII to ligate the thiostrepton resis- 10.0, 6.4 Hz), 5.03 (d, 1H, J 	 3.4 Hz), 5.85 (dd, 1H, J 	 14.8, 10.0
tance gene into pKOS231-183D digested with the same enzymes, Hz), 6.11 (dd, 1H, J 	 14.8, 11.2 Hz), 6.28 (d, 1H, J 	 14.8 Hz), 7.19
which created the expression vector pKOS342-108D. (dd, 1H, J 	 14.8, 11.2 Hz), 9.37 (s, 1H); 13C NMR (100 MHz, CDCl3)
 ppm 15.87, 17.29, 17.88, 18.16, 18.94, 25.31, 31.89, 32.32, 38.03,
40.81, 41.88, 43.21, 44.67, 45.75, 61.81, 65.93, 67.58, 68.70, 69.35,Constructs for Expression of 16-MM PKS Genes in S. fradiae
Characterization of the chalcomycin gene cluster and construction 71.70, 73.05, 74.95, 73.05, 76.33, 79.16, 85.28, 96.39, 103.94, 122.29,
129.41, 143.36, 147.74, 173.22, 202.35, 202.45; HRMS calc. forof an expression plasmid containing the first two chalcomycin PKS
genes, pKOS232-172, are described elsewhere [17]. To replace the C36H60NO13 [MH]: 714.40592; found: 714.40808.
To isolate 6-carboxymethyl-6-desethyl-14-methyl-5-O-mycami-C-terminal interaction domain of ChmGII with the corresponding
TylGII linker, a short fragment from the 3 end of tylGII was amplified nosylplatenolide (CDMP), clarified fermentation broth (1 liter) was
applied to a column of XAD-16 resin (500 ml). The column was elutedby PCR using the primers 5-TGAAGCTTCCCGCCACGCTGGTG-3,
5-CGTCTAGACAGGGTGTGAAACCG-3, and pKOS168-190 [30] as with water (3.5 liter), removing most of the yellow material, and then
with 33%, 50%, and 100% MeOH/H2O. Fractions eluting with 100%the template, which introduced a HindIII site corresponding to the
natural site in chmGII. The PCR product was digested with HindIII MeOH were pooled, and solvent was removed in vacuo to provide
a brown oil (920 mg). The oil was applied to a silica flash columnand XbaI and ligated into pKOS232-172 cut with the same enzymes
to create pKOS342-82. The insert of this plasmid was excised with and first eluted with 10%–100% acetone/hexane (2% NEt3) to
remove nonpolar material, followed by 0%–10% MeOH/CH2Cl2NdeI and XbaI and ligated with the vector portion of pKOS232-189
digested with NdeI and SpeI to give pKOS342-84. This plasmid was (2% NEt3). Fractions eluting in 10% MeOH/CH2Cl2 (2% NEt3) were
pooled and concentrated in vacuo to provide a yellow oil. The mate-moved into E. coli DH5/pUB307 and then into S. fradiae K264-
105.2 by conjugation to give the strain S. fradiae K342-84. rial was applied to a second silica flash column, eluting with 0%–
20% MeOH/CH2Cl2 (2% NEt3). Fractions eluting in 5%–10% MeOH/A natural, unique HindIII site near the 3 end of chmGII was used
to attach the chalcomycin genes to the last three spiramycin PKS CH2Cl2 (2% NEt3) were pooled and concentrated in vacuo to pro-
vide a yellow solid (40 mg). This material was subjected to HPLCgenes. The three spiramycin genes were assembled from subclones
of cosmid pKC1306 (unpublished Eli Lilly deposit NRRL B21499). A (150  212 mm 5  MetaChem Polaris C-18 column, 10 ml/min),
eluting with a gradient of 30%–100% A/B (A 	 5 mM NH4OAcHindIII site was introduced into srmGII at the same position as for
chmGII by PCR amplification using the following upstream primer: CH3CN:MeOH [4:1]; B 	 5 mM NH4OAc). Fractions eluting in 45%
A/B were pooled and concentrated in vacuo. Residual NH4OAc was5-ACACGCTTAAGACTGAAGCTTCCCGCGACCTCGTCTTC-3. The
other primer was downstream of a natural BamHI site, and thus an removed by application of the material to a silica flash plug and
elution with 10% MeOH/CH2Cl2 (2% NEt3). The product was con-800 bp AflII-BamHI fragment was isolated and ligated between the
same sites of pKOS231-114A, which attached the PCR product to centrated in vacuo to provide CDMP (0.018 g, 0.031 mmol) as a
white solid. 1H NMR (CD3OD, 400 MHz)  ppm 1.09 (d, 3H, J 	 6.4most of srmGIII down to a BsrGI site (pKOS232-178). The large SpeI
to BsrGI fragment of this vector was then ligated to the large BsrGI Hz), 1.18 (d, 3H, J 	 7.2 Hz), 1.30 (m, 6H), 1.67 (m, 3H), 2.29 (m, 2H),
2.37 (d, 1H, J 	 15.6 Hz), 2.56 (m, 3H), 2.95 (s, 6H), 3.11 (t, 1H, J 	to AvrII fragment of pKOS231-132, which contained the remainder
of srmGIII, as well as srmGIV and srmGV, to give pKOS232-182. 10.0 Hz), 3.25 (d, 1H, J 	 10.6 Hz), 3.31 (m, 1H), 3.36 (m, 1H), 3.52
(m, 1H), 3.55 (s, 3H), 3.88 (d, 1H, J 	 10.6 Hz), 4.03 (d, 1H, J 	 9.6The chmGI-II cassette as a NdeI-HindIII fragment (as described
in [17]), the srmGIII-V cassette as a HindIII-SpeI fragment, and the Hz), 4.52 (d, 1H, J 	 7.2 Hz), 4.78 (dquart, 1H, J 	 10.0, 6.4 Hz),
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5.91 (dd, 1H, J 	 14.8, 10.0 Hz), 6.31 (dd, 1H, J 	 14.8, 11.2 Hz), 5. Cox, K.L., Fishman, S.E., Larson, J.L., Stanzak, R., Reynolds,
P.A., Yeh, W.K., van Frank, R.M., Birmingham, V.A., Hersh-6.57 (d, 1H, J 	 14.8 Hz), 7.19 (dd, 1H, J 	 14.8, 11.2 Hz); 13C NMR
(100 MHz, CD3OD)  ppm 14.79, 16.38, 16.42, 16.87, 41.88, 32.06, berger, C.L., and Seno, E.T. (1986). The use of recombinant
DNA techniques to study tylosin biosynthesis and resistance in33.64, 34.83, 38.29, 40.78, 44.58, 45.16, 60.89, 67.80, 68.68, 69.61,
70.91, 72.67, 72.74, 79.33, 85.66, 102.99, 122.75, 129.76, 143.58, Streptomyces fradiae. J. Nat. Prod. 49, 971–980.
6. Fishman, S.E., Cox, K., Larson, J.L., Reynolds, P.A., Seno, E.T.,147.78, 171.99, 178.24, 204.49; HRMS calc. for C29H48NO11 [MH]:
586.32219; found: 586.32024. Yeh, W.K., Van Frank, R., and Hershberger, C.L. (1987). Cloning
genes for the biosynthesis of a macrolide antibiotic. Proc. Natl.To purify 12,16-didesmethyl-DMT, clarified fermentation broth
(1.15 liter) was adjusted to pH 7.8 with NaHCO3, the solution filtered, Acad. Sci. USA 84, 8248–8252.
7. Baltz, R.H., and Seno, E.T. (1988). Genetics of Streptomycesand the filtrate extracted with CH2Cl2 (4  850 ml). The combined
organic extracts were dried over Na2SO4, filtered, and concentrated fradiae and tylosin biosynthesis. Annu. Rev. Microbiol. 42,
547–574.in vacuo to provide a yellow semisolid (377 mg). This material was
applied to a silica flash column, eluting with 10%–60% acetone/ 8. Merson-Davies, L.A., and Cundliffe, E. (1994). Analysis of five
tylosin biosynthetic genes from the tyllBA region of the Strepto-hexane (2% NEt3). Fractions eluting in 30% acetone/hexane (2%
myces fradiae genome. Mol. Microbiol. 13, 349–355.NEt3) were pooled and solvent was removed in vacuo to provide an
9. Gandecha, A.R., Large, S.L., and Cundliffe, E. (1997). Analysisoff-white solid (73 mg). This material was subjected to HPLC (150 
of four tylosin biosynthetic genes from the tylLM region of the212 mm 5  MetaChem Polaris C-18 column, 10 ml/min), eluting
Streptomyces fradiae genome. Gene 184, 197–203.with a gradient of 50%–100% A/B (A 	 5 mM NH4OAc CH3CN:MeOH
10. Bate, N., and Cundliffe, E. (1999). The mycinose-biosynthetic[4:1]; B 	 5 mM NH4OAc). Fractions eluting between 20 and 25 min
genes of Streptomyces fradiae, producer of tylosin. J. Ind. Mi-were pooled and partitioned between CH2Cl2 and aqueous saturated
crobiol. Biotechnol. 23, 118–122.NaHCO3 to remove residual NH4OAc. The organic extracts were
11. Cundliffe, E. (1999). Organization and control of the tylosin-combined, dried over Na2SO4, and filtered. Hexane was added until
biosynthetic genes of Streptomyces fradiae. Actinomycetolog-the solution became cloudy and solvent was removed in vacuo to
ica 13, 68–75.provide a white solid (25.5 mg). The material was subjected to a
12. Fouces, R., Mellado, E., Diez, B., and Barredo, J.L. (1999). Thesecond round of HPLC, as just described, to provide 12,16-dides-
tylosin biosynthetic cluster from Streptomyces fradiae: geneticmethyl-DMT (12 mg) as a white powder. The structure was verified
organization of the left region. Microbiol. 145, 855–868.by 1H, 13C, COSY, multiplicity edited HSQC, and HMBC. 1H NMR
13. Bate, N., Butler, A.R., Smith, I.P., and Cundliffe, E. (2000). The(CDCl3, 400 MHz ),  ppm 9.65 (s, 1H, 19-CHO), 7.26 (dd, 1H, 11-H,
mycarose-biosynthetic genes of Streptomyces fradiae, pro-J11-10 	 14.8 Hz, J11-12 	 14.8 Hz), 6.28 (d, 1H, 10-H, J10-11 	 15.2 Hz),
ducer of tylosin. Microbiol. 146, 139–146.6.18 (dd, 1H, 12-H), 6.15 (dd, 1H, 13-H), 5.10 (dq, 1H, 15-H, J15-14 	
14. Cundliffe, E., Bate, N., Butler, A., Fish, S., Gandecha, A., and10 Hz, J15-16 	 6.4 Hz), 5.00 (d, 1H, 1″-H, J1″-2″ 	 3.2 Hz), 4.20 (d, 1H,
Merson-Davies, L. (2001). The tylosin-biosynthetic genes of1-H, J1-2 	 7.2 Hz), 4.05 (dq, 1H, 5″-H, J 	 9.6 Hz & 6 Hz), 3.84 (d,
Streptomyces fradiae. Antonie Van Leeuwenhoek 79, 229–234.1H, 3-H, J3-2 	 10 Hz), 3.74 (d, 2H, 21-H, J21-14 	 4.8 Hz), 3.70 (d, 1H,
15. Richardson, M.A., Kuhstoss, S., Huber, M.L., Ford, L., Godfrey,5-H, J5-4 	 9.2 Hz), 3.52 (dd, 1H, 2-H, J2-1 	 7.6 Hz, J2-3 	 10.2
O., Turner, J.R., and Rao, R.N. (1990). Cloning of spiramycinHz), 3.24 (1H, 4-H, overlapped with 5), 3.24 (1H, 5-H, overlapped
biosynthetic genes and their use in constructing Streptomyceswith 4), 2.93 (d, 1H, 4″-H, J4″-5″	 10 Hz), 2.87 (dd, 1H, 18a-H, J18a-18b 	
ambofaciens mutants defective in spiramycin biosynthesis. J.18 Hz, J18-19 	 8.4 Hz), 2.56 (m, 1H, 8-H), 2.56 (1H, 2a-H, overlapped
Bacteriol. 172, 3790–3798.with 8-H), 2.47 (s, 6H, 3-NMe2), 2.46 (1H, H-3, overlapped with 3-
16. Kuhstoss, S., Huber, M., Turner, J.R., Paschal, J.W., and Rao,NMe2), 2.35 (m, 1H, 14-H), 2.04 (dd, 1H, 2″a-H), 2.00 (dd, 1H, 2b-H),
R.N. (1996). Production of a novel polyketide through the con-2.00 (dd, 1H, 2″-a), 1.74 (dd, 1H, 2″b-H, J2″a-2″b 	 14.4, Hz J1″-2″ 	 3.6
struction of a hybrid polyketide synthase. Gene 183, 231–236.Hz), 1.68 (m, 1H, 4-H), 1.59 (m, 1H, 6-H), 1.32 (d, 3H, 16-H, J16-15 	
17. Ward, S.L., Hu, Z., Schirmer, A., Reid, R., Revill, W.P., Reeves,6.4 Hz), 1.27 (d, 3H, 6″-H, J6″-5″ 	 6.4 Hz), 1.24 (m, 2H, 7-H), 1.23 (d,
C.D., Petrakovsky, O.V., Dong, S.D., and Katz, L. (2004). The3H, 6-H, J6-5 	 7.6 Hz), 1.22 (s, 3H, 3″-Me), 1.17 (d, 3H, 20-H, J20-8 	
chalcomycin biosynthesis gene cluster from Streptomyces biki-6.8 Hz), 1.00 (d, 3H, 17-H, J17-4 	 6.8 Hz) . 13C NMR (CDCl3, 100 MHz),
niensis: novel features of an unusual ketolide through expres- ppm 203.0 (C-9), 202.7 (C-19), 173.4 (C-1), 143.5 (C-13), 143.1
sion of the chm PKS in Streptomyces fradiae. Antimicrob.(C-11), 131.8 (C-12), 122.6 (C-10), 103.6 (C-1), 96.4 (C-1″), 80.8 (C-5),
Agents Chemother., in press.76.3 (C-4″), 74.9 (C-4), 73.1 (C-5), 71.7 (C-2), 69.5 (C-15), 69.4
18. Pernodet, J.L., Boccard, F., Alegre, M.T., Blondelet-Rouault,(C-3″), 69.4 (C-3), 68.6 (C-3), 65.9 (C-5″), 61.8 (C-21), 53.5 (C14),
M.H., and Guerineau, M. (1988). Resistance to macrolides, lin-44.6 (C-8), 43.4 (C-18), 41.9 (3-NMe2), 40.8 (C-2″), 39.8 (C-2), 32.1
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